Evidence map›Paper›PMID 31700003›Full record

ArticleScientific reports2019

MicroRNA-495 downregulates AQP1 and facilitates proliferation and differentiation of osteoblasts in mice with tibial fracture through activation of p38 MAPK signaling pathway.

Lei Zhu, Zun-Wen Lin, Gang Wang, Hong Zhang, Ben Liu, Qing-Jia Xu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lei ZhuDepartment of Hand Surgery, Department of Foot and Ankle Surgery, Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, P.R. China.
Zun-Wen LinDepartment of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, P.R. China.
Gang WangDepartment of Hand Surgery, Department of Foot and Ankle Surgery, Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, P.R. China.
Hong ZhangDepartment of Hand Surgery, Department of Foot and Ankle Surgery, Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, P.R. China.
Ben LiuDepartment of Hand Surgery, Department of Foot and Ankle Surgery, Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, P.R. China.
Qing-Jia XuDepartment of Hand Surgery, Department of Foot and Ankle Surgery, Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, 250012, P.R. China. xxu_qingjia@163.com.
Qilu Hospital of Shandong University · CNNanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoblasts are implicated in the building of the vertebrate skeleton. The current study aimed to investigate the role of microRNA-495 (miR-495) in the osteoblasts of mice with tibial fractures and the underlying mechanism involving in aquaporin-1 (AQP1) and the p38 mitogen-activated protein kinase (p38 MAPK) signaling pathway. Initially, a microarray-based analysis was performed to screen the differentially expressed genes and miRNAs associated with tibial fracture. Following the establishment of a tibial fracture mouse model, the positive rate of the AQP1 protein in the fracture tissue was detected by immunohistochemistry (IHC). Next, to verify the binding site between miR-495 on AQP1, bioinformatics data were employed in addition to the application of a dual-luciferase reporter gene assay. The osteoblast cell line MC3T3-E1 was treated with miR-495 mimic, miR-495 inhibitor and Anisomycin to explore the potent effects of miR-495 on proliferation and differentiation of osteoblasts in mice with tibial fracture. The expression of miR-495, AQP1, p38 MAPK, PCNA, Cyclin D1, OCN, and OPN was subsequently evaluated by RT-qPCR and Western blot analysis. Cell viability, the number of calcium nodules and alkaline phosphatase (ALP) activity were detected by MTT assay, alizarin red staining, and ALP activity assay, respectively. Our results revealed that miR-495 was down-regulated while AQP1 was up-regulated in the mice with tibial fractures. AQP1 was verified as a target gene of miR-495. When the cells were treated with overexpressed miR-495 or activated p38 MAPK signaling pathway, elevated expression of PCNA, Cyclin, D1, OCN, and OPN along with an increased amount of calcium nodules, higher cell viability, and enhanced ALP activity was detected, while the expression of AQP1 was reduced. Collectively, the key findings of the present study support the notion that overexpressed miR-495 may activate the p38 MAPK signaling pathway to inhibit AQP1 and to promote the proliferation and differentiation of osteoblasts in mice with tibial fracture.

Indexed as

Cell DifferentiationCell ProliferationDown-RegulationMAP Kinase Signaling SystemAnimalsAquaporin 1Cell LineMiceMicroRNAsOsteoblastsp38 Mitogen-Activated Protein KinasesTibial FracturesAqp1 protein, mouseAquaporin 1MicroRNAsMIRN495 microRNA, mousep38 Mitogen-Activated Protein Kinases

Identifiers

PMID31700003
PMCPMC6838328
OpenAlexW2984687054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.